Results 151 to 160 of about 9,712 (187)
Some of the next articles are maybe not open access.

Deconstructing iNKT cell development at single-cell resolution

Trends in Immunology, 2022
Invariant natural killer T (iNKT) cells are increasingly regarded as disease biomarkers and immunotherapeutic targets. However, a greater understanding of their biology is necessary to effectively target these cells in the clinic. The discovery of iNKT1/2/17 cell effector subsets was a milestone in our understanding of iNKT cell development and ...
Thomas Baranek   +2 more
exaly   +4 more sources

INKT CELLS IN DISLIPIDEMIA.

open access: yes, 2014
Natural killer T cells (NKT) are T lymphocytes with a reactivity directed against glycolipid antigens presented by MHC-like CD1d molecules expressed by antigen presenting cells (APC). A large proportion of these cells (invariant NKT cells (iNKT)) possess strong immunomodulatory properties which impose a profound impact on the development and course of ...
S. Bondarenko
openaire   +2 more sources

Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting [PDF]

open access: yesCancer Cell, 2018
Chimeric antigen receptor anti-CD19 (CAR19)-T cell immunotherapy-induced clinical remissions in CD19+ B cell lymphomas are often short lived. We tested whether CAR19-engineering of the CD1d-restricted invariant natural killer T (iNKT) cells would result ...
Antonia Rotolo   +2 more
exaly   +4 more sources

The interaction between iNKT cells and B cells

Journal of Leukocyte Biology, 2021
AbstractInvariant natural killer T cells (iNKTs) bridge the innate immunity with the adaptive immunity and their interaction with B cells has been extensively studied. Here, we give a complete overview of these two cells, from their mechanism of interaction to clinical prospects and existing problems.
Tong, Zhu   +9 more
openaire   +2 more sources

A nano-engager for iNKT cells in cancer

Nature Cancer, 2020
Invariant natural killer T cells (iNKT cells) are innate-like CD1d-restricted T cells that have NK cell–like properties and bear an invariant T cell receptor (iTCR). iNKT cells have shown potential for cancer immunotherapy. A study now shows that stabilization of the iTCR–CD1d complex via a single-chain bi-specific antibody stimulates iNKT cell ...
Mark A. Exley   +2 more
openaire   +2 more sources

iNKT-Cell Responses to Glycolipids

Critical Reviews in Immunology, 2005
Invariant natural killer T (iNKT) cells are an unusual group of T lymphocytes that recognize glycolipid antigens presented by the major histocompatibility complex class I-related protein CD1d. Because iNKT cells play a regulatory role in the immune system, they are attractive targets for immunotherapy.
Vrajesh V, Parekh   +2 more
openaire   +2 more sources

Adjuvant activity mediated by iNKT cells

Seminars in Immunology, 2010
Invariant natural killer T (iNKT) cells have adjuvant activity due to their ability to produce large amounts of IFN-gamma, which activates other cells in innate and acquired systems, and orchestrates protective immunity. Based on these adjuvant mechanisms, we developed iNKT cell-targeted adjuvant therapy and carried out a phase I/IIa trial on advanced ...
Shinichiro, Fujii   +5 more
openaire   +2 more sources

iNKT Cells in Allergic Disease

2007
Recent studies indicate that invariant TCR+ CD1d-restricted natural killer T (iNKT) cells play an important role in regulating the development of asthma and allergy. iNKT cells can function to skew adaptive immunity toward Th2 responses, or can act directly as effector cells at mucosal surfaces in diseases such as ulcerative colitis and bronchial ...
E H, Meyer, R H, DeKruyff, D T, Umetsu
openaire   +2 more sources

Mechanism of regulation of autoimmunity by iNKT cells

Cytokine, 2011
iNKT cells, CD1d dependent natural killer T cells are a unique population of T cells. The capacity of iNKT cells to produce regulatory cytokines first provided an indication of their regulatory potential. Later on, in experimental models as well as in patients afflicted with an auto-immune disease, such as Type 1 diabetes mellitus, multiple sclerosis ...
Jan, Novak, Agnes, Lehuen
openaire   +2 more sources

iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome

Clinical Immunology, 2019
Invariant natural killer T cells (iNKT) produce large amounts of different cytokines which can influence differentiation, polarization and activation of immune cells, particularly NK and T cells. iNKT have been shown to suppress GvHD and promote anti-tumor and anti-pathogen immunity.
Mohammad, Fereidouni   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy